175 related articles for article (PubMed ID: 32205231)
1. High payload and targeted release of anthracyclines by aptamer-tethered DNA nanotrains - Thermodynamic and release kinetic study.
Pei W; Liu M; Wu Y; Zhao Y; Liu T; Sun B; Liu Y; Wang Q; Han J
Eur J Pharm Sci; 2020 May; 148():105319. PubMed ID: 32205231
[TBL] [Abstract][Full Text] [Related]
2. A Novel AS1411 Aptamer-Based Three-Way Junction Pocket DNA Nanostructure Loaded with Doxorubicin for Targeting Cancer Cells in Vitro and in Vivo.
Taghdisi SM; Danesh NM; Ramezani M; Yazdian-Robati R; Abnous K
Mol Pharm; 2018 May; 15(5):1972-1978. PubMed ID: 29669200
[TBL] [Abstract][Full Text] [Related]
3. Double targeting and aptamer-assisted controlled release delivery of epirubicin to cancer cells by aptamers-based dendrimer in vitro and in vivo.
Taghdisi SM; Danesh NM; Ramezani M; Lavaee P; Jalalian SH; Robati RY; Abnous K
Eur J Pharm Biopharm; 2016 May; 102():152-8. PubMed ID: 26987703
[TBL] [Abstract][Full Text] [Related]
4. Self-assembled, aptamer-tethered DNA nanotrains for targeted transport of molecular drugs in cancer theranostics.
Zhu G; Zheng J; Song E; Donovan M; Zhang K; Liu C; Tan W
Proc Natl Acad Sci U S A; 2013 May; 110(20):7998-8003. PubMed ID: 23630258
[TBL] [Abstract][Full Text] [Related]
5. A pH-sensitive DNA tetrahedron for targeted release of anthracyclines: Binding properties investigation and cytotoxicity evaluation.
Weng T; Wang L; Zhang X; Wu Y; Zhao Y; Zhang Y; Han J; Liu M
Int J Biol Macromol; 2022 Dec; 223(Pt A):766-778. PubMed ID: 36372106
[TBL] [Abstract][Full Text] [Related]
6. Cancer-Targeted Controlled Delivery of Chemotherapeutic Anthracycline Derivatives Using Apoferritin Nanocage Carriers.
KurzÄ…tkowska K; Pazos MA; Herschkowitz JI; Hepel M
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572999
[TBL] [Abstract][Full Text] [Related]
7. Aptamer-Modified Tetrahedral DNA Nanostructures as Drug Delivery System for Cancer Targeted Therapy.
Zhao R; Bai Y; Guo Y; Feng F; Shuang S
Macromol Biosci; 2024 Apr; 24(4):e2300420. PubMed ID: 38088938
[TBL] [Abstract][Full Text] [Related]
8. Self-Assembled DNA Nanocentipede as Multivalent Drug Carrier for Targeted Delivery.
Li W; Yang X; He L; Wang K; Wang Q; Huang J; Liu J; Wu B; Xu C
ACS Appl Mater Interfaces; 2016 Oct; 8(39):25733-25740. PubMed ID: 27622459
[TBL] [Abstract][Full Text] [Related]
9. Targeted delivery of doxorubicin to cancer cells by a cruciform DNA nanostructure composed of AS1411 and FOXM1 aptamers.
Abnous K; Danesh NM; Ramezani M; Charbgoo F; Bahreyni A; Taghdisi SM
Expert Opin Drug Deliv; 2018 Nov; 15(11):1045-1052. PubMed ID: 30269603
[TBL] [Abstract][Full Text] [Related]
10. Double targeting, controlled release and reversible delivery of daunorubicin to cancer cells by polyvalent aptamers-modified gold nanoparticles.
Taghdisi SM; Danesh NM; Lavaee P; Emrani AS; Hassanabad KY; Ramezani M; Abnous K
Mater Sci Eng C Mater Biol Appl; 2016 Apr; 61():753-61. PubMed ID: 26838906
[TBL] [Abstract][Full Text] [Related]
11. Precision-Guided Missile-Like DNA Nanostructure Containing Warhead and Guidance Control for Aptamer-Based Targeted Drug Delivery into Cancer Cells in Vitro and in Vivo.
Ouyang C; Zhang S; Xue C; Yu X; Xu H; Wang Z; Lu Y; Wu ZS
J Am Chem Soc; 2020 Jan; 142(3):1265-1277. PubMed ID: 31895985
[TBL] [Abstract][Full Text] [Related]
12. A controllable aptamer-based self-assembled DNA dendrimer for high affinity targeting, bioimaging and drug delivery.
Zhang H; Ma Y; Xie Y; An Y; Huang Y; Zhu Z; Yang CJ
Sci Rep; 2015 May; 5():10099. PubMed ID: 25959874
[TBL] [Abstract][Full Text] [Related]
13. Self-assembly of DNA nanostructure containing cell-specific aptamer as a precise drug delivery system for cancer therapy in non-small cell lung cancer.
Wang N; Yu C; Xu T; Yao D; Zhu L; Shen Z; Huang X
J Nanobiotechnology; 2022 Nov; 20(1):486. PubMed ID: 36403038
[TBL] [Abstract][Full Text] [Related]
14. A multi-storey DNA nanostructure containing doxorubicin and AS1411 aptamer for targeting breast cancer cells.
Yaghoobi E; Zavvar T; Ramezani M; Alibolandi M; Rahimzadeh Oskuei S; Zahiri M; Alinezhad Nameghi M; Abnous K; Taghdisi SM
J Drug Target; 2022 Dec; 30(10):1106-1112. PubMed ID: 35736221
[TBL] [Abstract][Full Text] [Related]
15. Thermodynamic and cellular studies of doxorubicin/daunorubicin loaded by a DNA tetrahedron for diagnostic imaging, chemotherapy, and gene therapy.
Li X; Wu Y; Zhang X; Liu J; Zhang Y; Yuan L; Liu M
Int J Biol Macromol; 2023 Nov; 251():126245. PubMed ID: 37562474
[TBL] [Abstract][Full Text] [Related]
16. Aptamer-Functionalized and Backbone Redox-Responsive Hyperbranched Polymer for Targeted Drug Delivery in Cancer Therapy.
Zhuang Y; Deng H; Su Y; He L; Wang R; Tong G; He D; Zhu X
Biomacromolecules; 2016 Jun; 17(6):2050-62. PubMed ID: 27113017
[TBL] [Abstract][Full Text] [Related]
17. Bioinspired DNA nanocockleburs for targeted delivery of doxorubicin.
Sun S; Cheraga N; Jiang HN; Xiao QR; Gao PC; Wang Y; Wei YY; Wang XW; Jiang Y
Colloids Surf B Biointerfaces; 2020 Feb; 186():110733. PubMed ID: 31864113
[TBL] [Abstract][Full Text] [Related]
18. Targeted and controlled release delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer-modified gold nanoparticles.
Danesh NM; Lavaee P; Ramezani M; Abnous K; Taghdisi SM
Int J Pharm; 2015 Jul; 489(1-2):311-7. PubMed ID: 25936625
[TBL] [Abstract][Full Text] [Related]
19. Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect.
Wiradharma N; Tong YW; Yang YY
Biomaterials; 2009 Jun; 30(17):3100-9. PubMed ID: 19342093
[TBL] [Abstract][Full Text] [Related]
20. Targeted delivery of Epirubicin to cancer cells by PEGylated A10 aptamer.
Taghdisi SM; Danesh NM; Sarreshtehdar Emrani A; Tabrizian K; Zandkarimi M; Ramezani M; Abnous K
J Drug Target; 2013 Sep; 21(8):739-44. PubMed ID: 23815443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]